Possible benefits for patients: May treat anxiety via calming the mind, and may stabilize mood
10.1161/CIRCULATIONAHA.120.052671 84
If GLP-1 agonists show superior neuroprotective benefits, this could challenge the traditional treatment paradigm and support initiating therapy with GLP-1 agonists in selected patients. GLP-1 agonists have demonstrated mechanisms that include reducing neuroinflammation, enhancing cerebral glucose metabolism, and improving synaptic plasticity, Wu added
Medication interactions, alcohol use, sleep apnea, anxiety, and depression can all affect sleep more than labs show
The observed ion is then the ligand alone, which is a real analytical outcome and not evidence that the sample lacked copper
Lastly, we discuss how the timing of ischemic onset increases morning resistance to thrombolytic therapy and the risk of hemorrhagic transformation